<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="40596">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02577887</url>
  </required_header>
  <id_info>
    <org_study_id>SJM-CIP-10073</org_study_id>
    <nct_id>NCT02577887</nct_id>
  </id_info>
  <brief_title>Advanced Bradycardia Device Feature Utilization and Clinical Outcomes II</brief_title>
  <acronym>BRADYCARE II</acronym>
  <official_title>Advanced Bradycardia Device Feature Utilization and Clinical Outcomes II</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Jude Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Jude Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to characterize the utilization of diagnostics capabilities in
      St. Jude Medical pacemakers to manage patients with a standard bradycardia pacing
      indication.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">August 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Complication rate in general pacemaker population</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of pacemakers patients programmed with advanced pacemaker features</measure>
    <time_frame>1 year</time_frame>
    <description>Advanced pacemaker features include Autocapture, Auto sensitivity control (ASC), Ventricular Intrinsic Preference (VIP®), Patient Notifier, RF telemetry, and newer advanced features.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of pacemakers patients with AT/AF, VT/VF, PMT and AMS episodes</measure>
    <time_frame>1 year</time_frame>
    <description>Episodes of AT/AF, VT/VF, PMT and AMS will be measured by the pacemakers diagnostics features.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of MRI scans received in pacemaker patients by country</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of MRI scans received in pacemaker patients by country</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">2016</enrollment>
  <condition>Standard Bradycardia Pacing Indication</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Patients implanted with a St. Jude Medical pacemakers</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with a standard bradycardia pacing indication and implanted with a St. Jude
        Medical pacemaker
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who have been implanted with an SJM Assurity MRI™, Endurity MRI™ or other
             SJM MRI compatible pacemakers in the EMEA region within 30 days or patients implanted
             with an Accent MRI™, Assurity MRI™, Endurity MRI™ or other SJM MRI compatible
             pacemakers in the Asia-Pac region within 30 days.

          -  Patient is geographically stable and willing to comply with the required follow-up
             schedule.

          -  Patient is not pregnant or planning to become pregnant during the course of the
             study.

          -  Patient is &gt; 18 years of age

        Exclusion Criteria:

          -  Patient's life expectancy is less than 1 year
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Pascale Ducloux</last_name>
    <phone>+322774609</phone>
    <email>pducloux@sjm.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Grant Kim</last_name>
    <phone>+18184933147</phone>
    <email>gkim@sjm.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>114 Avenue d'Arès</name>
      <address>
        <city>Bordeaux</city>
        <zip>33074</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Sylvain Reuter, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kliniken der Friedrich-Alexander-Universität</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Martin Arnold, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Via Palermo 636</name>
      <address>
        <city>Catania</city>
        <zip>951200</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Michele Massimo Gulizia, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>2-15 Yamadaoka</name>
      <address>
        <city>Suita-shi</city>
        <zip>565-0871</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Yasushi Sakata, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Japan</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <lastchanged_date>May 18, 2016</lastchanged_date>
  <firstreceived_date>October 6, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Bradycardia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
